GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Albert David Ltd (BOM:524075) » Definitions » COGS-to-Revenue

Albert David (BOM:524075) COGS-to-Revenue : 0.34 (As of Mar. 2024)


View and export this data going back to 2000. Start your Free Trial

What is Albert David COGS-to-Revenue?

Albert David's Cost of Goods Sold for the three months ended in Mar. 2024 was ₹303 Mil. Its Revenue for the three months ended in Mar. 2024 was ₹891 Mil.

Albert David's COGS to Revenue for the three months ended in Mar. 2024 was 0.34.

Cost of Goods Sold is directly linked to profitability of the company through Gross Margin. Albert David's Gross Margin % for the three months ended in Mar. 2024 was 66.01%.


Albert David COGS-to-Revenue Historical Data

The historical data trend for Albert David's COGS-to-Revenue can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Albert David COGS-to-Revenue Chart

Albert David Annual Data
Trend Mar15 Mar16 Mar17 Mar18 Mar19 Mar20 Mar21 Mar22 Mar23 Mar24
COGS-to-Revenue
Get a 7-Day Free Trial Premium Member Only Premium Member Only 0.34 0.36 0.38 0.36 0.35

Albert David Quarterly Data
Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24
COGS-to-Revenue Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 0.39 0.34 0.34 0.37 0.34

Albert David COGS-to-Revenue Calculation

Albert David's COGS to Revenue for the fiscal year that ended in Mar. 2024 is calculated as

COGS to Revenue=Cost of Goods Sold / Revenue
=1264.013 / 3624.617
=0.35

Albert David's COGS to Revenue for the quarter that ended in Mar. 2024 is calculated as

COGS to Revenue=Cost of Goods Sold / Revenue
=302.714 / 890.576
=0.34

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Albert David  (BOM:524075) COGS-to-Revenue Explanation

Cost of Goods Sold is directly linked to profitability of the company through Gross Margin.

Albert David's Gross Margin % for the three months ended in Mar. 2024 is calculated as:

Gross Margin %=1 - COGS to Revenue
=1 - Cost of Goods Sold / Revenue
=1 - 302.714 / 890.576
=66.01 %

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

A company that has a moat can usually maintain or even expand their Gross Margin. A company can increase its Gross Margin in two ways. It can increase the prices of the goods it sells and keeps its Cost of Goods Sold unchanged. Or it can keep the sales price unchanged and squeeze its suppliers to reduce the Cost of Goods Sold. Warren Buffett believes businesses with the power to raise prices have moats.


Albert David COGS-to-Revenue Related Terms

Thank you for viewing the detailed overview of Albert David's COGS-to-Revenue provided by GuruFocus.com. Please click on the following links to see related term pages.


Albert David (BOM:524075) Business Description

Traded in Other Exchanges
Address
8, Netaji Subhas Road, D-Block, 3rd Floor, Gillander House, Kolkata, WB, IND, 700001
Albert David Ltd is engaged in the manufacturing and trading of pharmaceutical products. The company offers products such as pharmaceutical formulations, infusion solutions, herbal dosage forms, and bulk drugs. Its formulation product covers parenteral, oral, and enteral, topical agents, and vision care solutions. The company exports its product to regions like Latin America, South East Asia, and a few African countries.

Albert David (BOM:524075) Headlines

No Headlines